You are here:

Home
NICE Guidance
Conditions and diseases
Diabetes and other endocrinal, nutritional and metabolic conditions
Faltering growth

Human growth hormone (somatropin) for the treatment of growth failure in children

Technology appraisal guidance
Reference number: TA188
Published: 26 May 2010

Guidance
Tools and resources
Information for the public
Evidence
History

Consultee and commentator comments on the ACD

Manufacturers
Professional and Patient Groups
Other
Commentators

This page was last updated: 30 March 2010